In 2019, our Ride community will stop cancer in its tracks by purchasing a critical, state-of-the-art cervical cancer diagnostic unit for cervical cancer; the most effective and minimally-invasive way to diagnose and treat precancerous cell changes before they even develop into cancer.

We will help bring Atlantic Canada’s first surgical robotics system to the QEII – giving prostate cancer patients shorter hospitals stays, less pain, quicker recovery times and, most importantly, a decreased risk of the cancer advancing or recurring.

This year, our Ride community will also fund groundbreaking research to discover new treatments and cures for blood cancer, as well as individualized support programs for cancer patients and their families through The Leukemia & Lymphoma Society of Canada.